1-12 of 12
Elizabeth J. Shpall
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Enhancement of High-Dose Chemotherapy and Autologous SCT with the PARP Inhibitor Olaparib for Refractory Lymphoma

Available to Purchase
Yago Nieto, Jeremy Ramdial, Benigno Valdez, Peter F. Thall, Roland Bassett, Melissa Barnett, Samer Srour, Chitra Hosing, Amin Alousi, Muzaffar Qazilbash, Uday Popat, Alison Gulbis, Terri Lynn Shigle, Sairah Ahmed, Maria Guillermo Pacheco, Richard Champlin, Elizabeth J. Shpall, Borje S. Andersson
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (6): 975–982.
https://doi.org/10.1158/1078-0432.CCR-24-3544
Published: 17 March 2025
View articletitled, Enhancement of High-Dose Chemotherapy and Autologous SCT with the PARP Inhibitor Olaparib for Refractory Lymphoma
Open the PDF for Enhancement of High-Dose Chemotherapy and Autologous SCT with the PARP Inhibitor Olaparib for Refractory Lymphoma in another window
Includes: Supplementary data
Journal Articles

Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood–Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies

Free
Lucila N. Kerbauy, Nancy D. Marin, Mecit Kaplan, Pinaki P. Banerjee, Melissa M. Berrien-Elliott, Michelle Becker-Hapak, Rafet Basar, Mark Foster, Luciana Garcia Melo, Carly C. Neal, Ethan McClain, May Daher, Ana Karen Nunez Cortes, Sweta Desai, Francesca Wei Inng Lim, Mayela Carolina Mendt, Timothy Schappe, Li Li, Hila Shaim, Mayra Shanley, Emily L. Ensley, Nadima Uprety, Pamela Wong, Enli Liu, Sonny O. Ang, Rong Cai, Vandana Nandivada, Vakul Mohanty, Qi Miao, Yifei Shen, Natalia Baran, Natalie W. Fowlkes, Ken Chen, Luis Muniz-Feliciano, Richard E. Champlin, Yago L. Nieto, Joachim Koch, Martin Treder, Wolfgang Fischer, Oswaldo Keith Okamoto, Elizabeth J. Shpall, Todd A. Fehniger, Katayoun Rezvani
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (13): 3744–3756.
https://doi.org/10.1158/1078-0432.CCR-21-0164
Published: 01 July 2021
View articletitled, Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood–Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies
Open the PDF for Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood–Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies in another window
Includes: Supplementary data
Journal Articles

Safety and Efficacy of Vorinostat Plus Sirolimus or Everolimus in Patients with Relapsed Refractory Hodgkin Lymphoma

Available to Purchase
Filip Janku, Haeseong Park, S. Greg Call, Kiran Madwani, Yasuhiro Oki, Vivek Subbiah, David S. Hong, Aung Naing, Vivianne M. Velez-Bravo, Tamara G. Barnes, Fredrick B. Hagemeister, Gerald S. Falchook, Daniel D. Karp, Jennifer J. Wheler, Sarina A. Piha-Paul, Ignacio Garrido-Laguna, Elizabeth J. Shpall, Luis E. Fayad, Sattva S. Neelapu, Funda Meric-Bernstam, Razelle Kurzrock, Michelle A. Fanale
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (21): 5579–5587.
https://doi.org/10.1158/1078-0432.CCR-20-1215
Published: 02 November 2020
View articletitled, Safety and Efficacy of Vorinostat Plus Sirolimus or Everolimus in Patients with Relapsed Refractory Hodgkin Lymphoma
Open the PDF for Safety and Efficacy of Vorinostat Plus Sirolimus or Everolimus in Patients with Relapsed Refractory Hodgkin Lymphoma in another window
Includes: Supplementary data
Journal Articles

Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II Trial

Available to Purchase
Shiao-Pei Weathers, Marta Penas-Prado, Be-Lian Pei, Xiaoyang Ling, Cynthia Kassab, Pinaki Banerjee, Mustafa Bdiwi, Hila Shaim, Abdullah Alsuliman, Mayra Shanley, John F. de Groot, Barbara J. O'Brien, Rebecca Harrison, Nazanin Majd, Carlos Kamiya-Matsuoka, Gregory N. Fuller, Jason T. Huse, Linda Chi, Ganesh Rao, Jeffrey S. Weinberg, Frederick F. Lang, Raymond Sawaya, Elizabeth J. Shpall, Katayoun Rezvani, Amy B. Heimberger
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (14): 3565–3577.
https://doi.org/10.1158/1078-0432.CCR-20-0176
Published: 15 July 2020
View articletitled, Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II Trial
Open the PDF for Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II Trial in another window
Includes: Supplementary data
Journal Articles

Fucosylation Enhances the Efficacy of Adoptively Transferred Antigen-Specific Cytotoxic T Lymphocytes

Free
Gheath Alatrash, Na Qiao, Mao Zhang, Madhushree Zope, Alexander A. Perakis, Pariya Sukhumalchandra, Anne V. Philips, Haven R. Garber, Celine Kerros, Lisa S. St. John, Maria R. Khouri, Hiep Khong, Karen Clise-Dwyer, Leonard P. Miller, Steve Wolpe, Willem W. Overwijk, Jeffrey J. Molldrem, Qing Ma, Elizabeth J. Shpall, Elizabeth A. Mittendorf
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (8): 2610–2620.
https://doi.org/10.1158/1078-0432.CCR-18-1527
Published: 15 April 2019
View articletitled, Fucosylation Enhances the Efficacy of Adoptively Transferred Antigen-Specific Cytotoxic T Lymphocytes
Open the PDF for Fucosylation Enhances the Efficacy of Adoptively Transferred Antigen-Specific Cytotoxic T Lymphocytes in another window
Includes: Supplementary data
Journal Articles

Phase II Feasibility and Pharmacokinetic Study of Concurrent Administration of Trastuzumab and High-Dose Chemotherapy in Advanced HER2+ Breast Cancer

Free
Yago Nieto, James J. Vredenburgh, Elizabeth J. Shpall, Scott I. Bearman, Peter A. McSweeney, Nelson Chao, David Rizzieri, Christina Gasparetto, Steve Matthes, Anna E. Barón, Roy B. Jones
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (21): 7136–7143.
https://doi.org/10.1158/1078-0432.CCR-04-0891
Published: 08 November 2004
View articletitled, Phase II Feasibility and Pharmacokinetic Study of Concurrent Administration of Trastuzumab and High-Dose Chemotherapy in Advanced HER2+ Breast Cancer
Open the PDF for Phase II Feasibility and Pharmacokinetic Study of Concurrent Administration of Trastuzumab and High-Dose Chemotherapy in Advanced HER2+ Breast Cancer in another window
Journal Articles

Prognostic Analysis of Early Lymphocyte Recovery in Patients with Advanced Breast Cancer Receiving High-Dose Chemotherapy with an Autologous Hematopoietic Progenitor Cell Transplant

Free
Yago Nieto, Elizabeth J. Shpall, Ian K. McNiece, Samia Nawaz, Julie Beaudet, Steve Rosinski, Julie Pellom, Victoria Slat-Vasquez, Peter A. McSweeney, Scott I. Bearman, James Murphy, Roy B. Jones
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (15): 5076–5086.
https://doi.org/10.1158/1078-0432.CCR-04-0117
Published: 05 August 2004
View articletitled, Prognostic Analysis of Early Lymphocyte Recovery in Patients with Advanced Breast Cancer Receiving High-Dose Chemotherapy with an Autologous Hematopoietic Progenitor Cell Transplant
Open the PDF for Prognostic Analysis of Early Lymphocyte Recovery in Patients with Advanced Breast Cancer Receiving High-Dose Chemotherapy with an Autologous Hematopoietic Progenitor Cell Transplant in another window
Journal Articles

Long-Term Analysis and Prospective Validation of a Prognostic Model for Patients with High-Risk Primary Breast Cancer Receiving High-Dose Chemotherapy

Free
Yago Nieto, Samia Nawaz, Elizabeth J. Shpall, Scott I. Bearman, James Murphy, Roy B. Jones
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (8): 2609–2617.
https://doi.org/10.1158/1078-0432.CCR-03-0536
Published: 20 April 2004
View articletitled, Long-Term Analysis and Prospective Validation of a Prognostic Model for Patients with High-Risk Primary Breast Cancer Receiving High-Dose Chemotherapy
Open the PDF for Long-Term Analysis and Prospective Validation of a Prognostic Model for Patients with High-Risk Primary Breast Cancer Receiving High-Dose Chemotherapy in another window
Journal Articles

A Predictive Model for Relapse in High-Risk Primary Breast Cancer Patients Treated with High-Dose Chemotherapy and Autologous Stem-Cell Transplant

Free
Yago Nieto, Pablo J. Cagnoni, Elizabeth J. Shpall, Xuesheng Xu, James Murphy, James Vredenburgh, Nelson J. Chao, Scott I. Bearman, Roy B. Jones
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (11): 3425–3431.
Published: 01 November 1999
View articletitled, A Predictive Model for Relapse in High-Risk Primary Breast Cancer Patients Treated with High-Dose Chemotherapy and Autologous Stem-Cell Transplant
Open the PDF for A Predictive Model for Relapse in High-Risk Primary Breast Cancer Patients Treated with High-Dose Chemotherapy and Autologous Stem-Cell Transplant in another window
Journal Articles

Phase II Trial of High-Dose Chemotherapy with Autologous Stem Cell Transplant for Stage IV Breast Cancer with Minimal Metastatic Disease

Free
Yago Nieto, Pablo J. Cagnoni, Elizabeth J. Shpall, Steve Matthes, Anna Barón, Roy B. Jones, Scott I. Bearman
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (7): 1731–1737.
Published: 01 July 1999
View articletitled, Phase II Trial of High-Dose Chemotherapy with Autologous Stem Cell Transplant for Stage IV Breast Cancer with Minimal Metastatic Disease
Open the PDF for Phase II Trial of High-Dose Chemotherapy with Autologous Stem Cell Transplant for Stage IV Breast Cancer with Minimal Metastatic Disease in another window
Journal Articles

Nonpredictable Pharmacokinetic Behavior of High-Dose Cyclophosphamide in Combination with Cisplatin and 1,3-Bis(2-chloroethyl)-1-nitrosourea

Free
Yago Nieto, Xuesheng Xu, Pablo J. Cagnoni, Steve Matthes, Elizabeth J. Shpall, Scott I. Bearman, James Murphy, Roy B. Jones
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (4): 747–751.
Published: 01 April 1999
View articletitled, Nonpredictable Pharmacokinetic Behavior of High-Dose Cyclophosphamide in Combination with Cisplatin and 1,3-Bis(2-chloroethyl)-1-nitrosourea
Open the PDF for Nonpredictable Pharmacokinetic Behavior of High-Dose Cyclophosphamide in Combination with Cisplatin and 1,3-Bis(2-chloroethyl)-1-nitrosourea in another window
Journal Articles

Acute Encephalopathy: A New Toxicity Associated with High-Dose Paclitaxel

Free
Yago Nieto, Pablo J. Cagnoni, Scott I. Bearman, Elizabeth J. Shpall, Steven Matthes, Todd DeBoom, Anna Barón, Roy B. Jones
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (3): 501–506.
Published: 01 March 1999
View articletitled, Acute Encephalopathy: A New Toxicity Associated with High-Dose Paclitaxel
Open the PDF for Acute Encephalopathy: A New Toxicity Associated with High-Dose Paclitaxel in another window